3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Immunoglobulin Light-chain Amyloidosis
3
Pleural Effusion, Malignant
2
Amyloidosis
2
Tuberous Sclerosis
1
Skin Toxicity
1
Ras-wildtype Colorectal Cancer
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Menstruation Disturbances
1
Lymphoma, Non-Hodgkin
1
Lymphangioleiomyomatosis
1
Intracranial Aneurysm
1
Hyperandrogenism
1
Hemangioma, Cavernous
1
Head and Neck Neoplasms
1
Exanthema
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Arteriovenous Malformations
1
Amyloidosis, Familial
1
Advanced Malignant Neoplasm
1
AA amyloidosis
1
Interventions
Metformin
2
drospirenone and ethinyl estradiol combination
1
cinnulin PF
1
Sugars
1
Population Groups
1
Inositol
1
Glucose Tolerance Test
1
Folic Acid
1
Doxycycline
1
Diet
1
Control Groups
1
Contraceptives, Oral
1
Caloric Restriction
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Menstruation Disturbances
×
Doxycycline
×
Clear all
NCT01788215
2016-01-13
MI-PCOS
University of Rochester
Phase 3
Completed
10 enrolled
14 charts